Patient Advisory Boards (PABs) better incorporate the patient voice, preferences, and community needs in the development of important new therapies. People living with lupus are the one who will ultimately benefit from any new treatment, and we believe their insight should be sought as early as possible. Lupus Therapeutics understands that to be patient centric you must co-create with patients and having a PAB for clinical trials moves the drug development process in that direction.
PABs can be conducted as a one-time service to address one question, or ideally, they can be formed as a council and serve for the duration of a study. PABs can be conducted both virtually and in-person. Lupus Therapeutics has the capabilities to recruit, manage contracting and screening, reporting feedback and serving as a conduit between PAB members and research organizations.
Our PABs provide valuable feedback on many aspects of clinical trials and research, including: